Next Article in Journal
Correction: Taha et al. Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis. Pharmaceuticals 2022, 15, 918
Next Article in Special Issue
Effects of Short-Term Treatment with α-Lipoic Acid on Neuropathic Pain and Biomarkers of DNA Damage in Patients with Diabetes Mellitus
Previous Article in Journal
The Use of Osteogenon as an Adjunctive Treatment in Lower Leg Fractures
Previous Article in Special Issue
Navigating Preclinical Models and Medications for Peripheral Neuropathy: A Review
 
 
Due to scheduled maintenance work on our servers, there may be short service disruptions on this website between 11:00 and 12:00 CEST on March 28th.
Article

Article Versions Notes

Pharmaceuticals 2024, 17(11), 1532; https://doi.org/10.3390/ph17111532
Action Date Notes Link
article html file updated 29 June 2025 18:33 CEST Update https://www.mdpi.com/1424-8247/17/11/1532/html
article html file updated 15 November 2024 09:11 CET Original file -
article supplementary file uploaded. 15 November 2024 09:10 CET - https://www.mdpi.com/1424-8247/17/11/1532#supplementary
article pdf uploaded. 15 November 2024 09:10 CET Version of Record https://www.mdpi.com/1424-8247/17/11/1532/pdf
article xml uploaded. 15 November 2024 09:10 CET Update https://www.mdpi.com/1424-8247/17/11/1532/xml
article xml file uploaded 15 November 2024 09:10 CET Original file -
Back to TopTop